Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume 125, Issue 7-8, Pages 200-219Publisher
SPRINGER WIEN
DOI: 10.1007/s00508-013-0337-z
Keywords
Ascites; Variceal bleeding; TIPS; Hepatorenal syndrome; Hepatopulmonary syndrome; Portopulmonary hypertension; Budd-Chiari Syndrome; Somatostatin; Terlipressin; Carvedilol
Categories
Funding
- Roche
- MSD
- Phenex Pharma
- Gilead Sciences
- Janssen
- Boston Scientific
- Cook Medical
- Ferring
Ask authors/readers for more resources
In November 2004, the Austrian Society of Gastroenterology and Hepatology (A-GGH) held for the first time a consensus meeting on the definitions and treatment of portal hypertension and its complications in the Billroth-Haus in Vienna, Austria (Billroth I-Meeting). This meeting was preceded by a meeting of international experts on portal hypertension with some of the proponents of the Baveno consensus conferences (http://www.oeggh.at/videos.asp). The consensus itself is based on the Baveno III consensus with regard to portal hypertensive bleeding and the suggestions of the International Ascites Club regarding the treatment of ascites. Those statements were modified by new knowledge derived from the recent literature and also by the current practice of medicine as agreed upon by the participants of the consensus meeting. In October 2011, the A-GGH organized the second consensus meeting on portal hypertension and its complications in Vienna (Billroth II-Meeting). The Billroth II-Guidelines on the definitions and treatment of portal hypertension and its complications take into account the developments of the last 7 years, including the Baveno-V update and several key publications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available